Next Quarterly Earnings
Friday, October 23, 2026
CW 43
Pre-Market
In 57 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Jiangsu Hengrui Medicine
Jiangsu Hengrui Medicine is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and distribution of innovative medicines. The company focuses on oncology, autoimmune diseases, pain management, and metabolic disorders to improve global patient care. It drives biopharmaceutical innovation forward.
Frequently asked questions
When will Jiangsu Hengrui Medicine report its next quarterly earnings?
Jiangsu Hengrui Medicine is scheduled to report its next quarterly earnings on 10/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Jiangsu Hengrui Medicine last report quarterly earnings?
Jiangsu Hengrui Medicine last reported quarterly earnings on 8/19/2026 (Q2 2026). Earnings per share (EPS) came in at 0.34 CNY.
How does Jiangsu Hengrui Medicine stock react to earnings?
Across its last 4 earnings reports, Jiangsu Hengrui Medicine stock moved by ±1.1% on average the following day. The largest reaction was +2.3% on 10/27/2025; 3 of 4 reactions were positive.
How often has Jiangsu Hengrui Medicine beaten expectations?
Jiangsu Hengrui Medicine has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
How do I add the Jiangsu Hengrui Medicine earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±1.1%
Avg. next-day move
+2.3%
Largest move (10/27/2025)
75%
Share of positive reactions
±4.1%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
1/3
Quarters above estimates
33.3%
Beat rate
-7.4%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Jiangsu Hengrui Medicine
Country
🇨🇳
More Financial Information